Warning: The NCBI web site requires JavaScript to function. more...
Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.
Agbottah ET, Traviss C, McArdle J, Karki S, St Laurent GC 3rd, Kumar A.
Retrovirology. 2007 Jun 12;4:41.
Related citations
Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T, Kaushik N, Pandey PK, Kashanchi F, Deng L, Pandey VN.
Biochemistry. 2000 Sep 26;39(38):11532-9.
Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB.
Virology. 1997 Aug 18;235(1):48-64.
Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
Jeyaseelan R, Kurabayashi M, Kedes L.
AIDS Res Hum Retroviruses. 1996 May 1;12(7):569-76.
Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
Rhim H, Rice AP.
Nucleic Acids Res. 1994 Oct 25;22(21):4405-13.
Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
Agbottah E, Deng L, Dannenberg LO, Pumfery A, Kashanchi F.
Retrovirology. 2006 Aug 7;3:48.
Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity.
Ivanova G, Reigadas S, Ittig D, Arzumanov A, Andreola ML, Leumann C, Toulmé JJ, Gait MJ.
Oligonucleotides. 2007 Spring;17(1):54-65.
Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
Endo-Munoz L, Warby T, Harrich D, McMillan NA.
Virol J. 2005 Feb 28;2:17.
Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
Arzumanov A, Walsh AP, Rajwanshi VK, Kumar R, Wengel J, Gait MJ.
Biochemistry. 2001 Dec 4;40(48):14645-54.
Synthetic HIV-1 Tat can dissociate HeLa nuclear protein-TAR RNA complexes in vitro: a novel Tat-nuclear protein interaction.
Jeyapaul J, Seshamma T, Khan SA.
Oncogene. 1991 Sep;6(9):1507-13.
HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M, Ansari SA, Chepenik LG, Pomerantz RJ, Khalili K, Rappaport J, Amini S.
J Hum Virol. 1999 Mar-Apr;2(2):72-80.
A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA.
Hart CE, Saltrelli MJ, Galphin JC, Schochetman G.
J Virol. 1995 Oct;69(10):6593-9.
Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
Lind KE, Du Z, Fujinaga K, Peterlin BM, James TL.
Chem Biol. 2002 Feb;9(2):185-93.
Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region.
Xie B, Invernizzi CF, Richard S, Wainberg MA.
J Virol. 2007 Apr;81(8):4226-34. Epub 2007 Jan 31.
Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.
Wu-Baer F, Sigman D, Gaynor RB.
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7153-7.
Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Lisziewicz J, Sun D, Smythe J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC.
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8000-4.
High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.
Churcher MJ, Lamont C, Hamy F, Dingwall C, Green SM, Lowe AD, Butler JG, Gait MJ, Karn J.
J Mol Biol. 1993 Mar 5;230(1):90-110.
Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
Xie B, Wainberg MA, Frankel AD.
J Virol. 2003 Feb;77(3):1984-91.
The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 2 trans-activation responsive region mediate Tat-2 transactivation.
Browning C, Hilfinger JM, Rainier S, Lin V, Hedderwick S, Smith M, Markovitz DM.
J Virol. 1997 Oct;71(10):8048-55.
Inhibitors of HIV-1 Tat-mediated transactivation.
Richter SN, Palù G.
Curr Med Chem. 2006;13(11):1305-15. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on